IMS: merger with TPG/CPPIB on track

Share this article:
IMS Health convened a special meeting to vote on its buyout offer, in what some consider a move to restore investor confidence in the deal.

At the Feb. 8 meeting, stockholders will be entitled to vote on the buyout. At press time, an IMS spokesman told MM&M that the final proxy was filed with SEC on Dec. 29, and that the company still believes the transaction will be completed by the end of the first quarter.

IMS shares plunged in December after reports swirled of a possible congressional amendment banning the collection of physicians' prescribing data for marketing purposes, a proposal which analysts said may have imperiled IMS's buyout deal.

The planned takeover by investment funds TPG Capital and CPP Investment Board, announced in November, is valued at $5.2 billion, including assumed debt.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"